Everolimus (EVE) + letrozole (LET) in patients (pts) with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4
Annals of Oncology, cilt.28, 2017 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 28
- Basım Tarihi: 2017
- Doi Numarası: 10.1093/annonc/mdx365.007
- Dergi Adı: Annals of Oncology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır